Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers
Early Tesla backer is developing financing plan to allow fresh shot at FDA approval for ecstasy-based PTSD treatment
Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’
Verdiva Bio wants to use potential drugs acquired in China to compete in growing obesity market
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in US
Moderna, Pfizer, CureVac and Novavax register gains as health agency stresses risk to public ‘remains low’
Research adds to evidence that viral infections contribute to development of dementia
Drugmaker becomes latest titan of corporate America to curry favour with president-elect
The progress of new discoveries must be celebrated
Retrenchment in industry has led to concerns about spread of ‘pharmacy deserts’ with limited access to medicines
Autolus hopes its less gruelling Car-T treatment for a type of leukaemia will allow it to compete with bigger rivals
Appetite will pick up as interest rates fall, but uneven distribution of funding and rewards looks set to persist
Regulatory go-ahead marks latest boost for drugmaker’s blockbuster anti-obesity franchise
Obesity treatment CagriSema misses goal of 25% reduction in body weight
Market will never be winner takes all given that different patients will have different requirements
Treatment for short bowel syndrome fails to win approval from US regulator
Boss David Epstein hopes to replicate his success at Seagen after $43bn sale last year
FTSE 100 group reportedly faces difficulties in selling drugs to Chinese hospitals
Deal with BC Partners aims to capitalise on rising demand for off-patent versions of complex drugs
Firm settles criminal investigation and former senior partner admits obstruction of justice
Funding for existing services would have helped more patients
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
Experts expect Trump regulators to be less hawkish on challenging proposed acquisitions in the sector
And quality in the small cap rally
Company veteran Iskra Reic moves to Shanghai after Leon Wang placed under investigation by authorities
